3 ASX shares I would buy and hold for a decade

When it comes to finding shares to buy and hold for an extended period, I think the healthcare and information technology sectors are great places to start looking.

This is because I feel both these sectors have a number of quality companies with strong long-term growth potential to choose from.

Here’s why I think the following three shares would be great buy and hold investment candidates:

Cochlear Limited (ASX: COH)

I think that this hearing solutions company could be a great buy and hold investment option due to the tailwinds it is experiencing from ageing populations across the globe. As people age, their hearing will more often than not fade. Untreated hearing loss has been shown to have serious emotional and social consequences for older people, which makes it vitally important that they look at assisted hearing products. As Cochlear’s products are arguably the best in their class, I believe it is positioned perfectly to continue delivering above-average profit growth for a long time to come.

CSL Limited (ASX: CSL)

This biotherapeutics company could be the ultimate buy and hold share. Over the last 10 years it has provided investors with an impressive average annual total return of 18.2%. The good news is that I believe this market-beating run could continue over the next few years. This is not only down to the success of its core business and the pipeline of products under development, but also its fast-growing Seqirus influenza business. Seqirus has been performing well ahead of expectations and I expect its strong growth to continue for some time to come.

Xero Limited (ASX: XRO)

One of the best buy and hold investment options in the tech sector in my opinion is this New Zealand-based accounting software provider. I have been very impressed at the way the company continues to win market share in the ANZ and UK markets. And although its US growth has been slower than expected, I remain confident that the quality of the product will allow it to successfully penetrate the lucrative market in the near future.

Finally, here are 3 top shares that I think could be the next Cochlear or Xero.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Xero. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.